Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to CHOP and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma. A prospective study by the Finnish Lymphoma Group.

Added 3487 days ago (10.03.2012)
Authors: Räty R, Honkanen T, Jantunen E, Jyrkkiö S, Karjalainen-Lindsberg ML, Kuittinen O, Lehto M, Mikkola M, Poikonen E, Rauhala A, Rimpiläinen J, Räsänen A, Siitonen S, Suominen M, Vapaatalo M, Elonen E
PubMed id: 22397313
Read article